We are thrilled to share with you that we have been awarded the 2015 Frost & Sullivan North American Open-Access R&D Technology Leadership Award.  The award is part of Frost & Sullivan’s Growth, Innovation & Leadership Award series, recognizing companies that have demonstrated excellence in devising and implementing strong growth strategies.

We were recognized for our outstanding achievement and strong performance in helping our customers improve their R&D productivity while reducing cost through a model of R&D enablement.  Frost & Sullivan views WuXi as an innovator in business relationships across the entire pharmaceutical and biotechnology value chain.

We are honored to play an important role in helping to bring better medicine to patients faster.  We are also thankful for the trust and support from our customers and collaborative partners in our journey.  Together with over 2,000 partners worldwide, we continue to advance breakthroughs in science and medicine that help people around the world lead happier and healthier lives.

 

Related Links:

WuXi Wins Prestigious SCRIP Award for “Best Company in the Emerging Market”